Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells

Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease and one of the cancer entities with the lowest life expectancy. Beside surgical therapy, no effective therapeutic options are available yet. Here, we show that 4-phenylbutyrate (4-PB), a known and well-tolerable inhibitor of histone deacetyl...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ammerpohl, O, Trauzold, A, Schniewind, B, Griep, U, Pilarsky, C, Grutzmann, R, Saeger, H-D, Janssen, O, Sipos, B, Kloppel, G, Kalthoff, H
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2007
Témata:
Translational Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360208/
https://ncbi.nlm.nih.gov/pubmed/17164759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603511
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky